Literature DB >> 9614875

Conversion of VP1 to VPg in cells infected by infectious pancreatic necrosis virus.

G Magyar1, H K Chung, P Dobos.   

Abstract

The RNA polymerase VP1 of IPNV (a bisegmented dsRNA containing virus) is present in the virion both as a free polypeptide and as a genome-linked protein (VPg). Virion VP1 primes viral RNA synthesis in vitro (P. Dobos, 1995, Virology 208, 19-25), and here we present data which suggest that protein-primed RNA synthesis may also take place in infectious pancreatic necrosis virus (IPNV)-infected cells. Anti-VP1 serum immunoprecipitated several polypeptides larger than the 94-kDa VP1 of IPNV from [35S]methionine-labeled infected cell lysates. During denaturing, SDS-polyacrylamide gel electrophoresis these polypeptides formed a characteristic "ladder" which was resistant to alkaline phosphatase but sensitive to RNases, indicating that it consisted of VP1 polypeptides with oligoribonucleotides of various lengths attached to them. Probing the ladder with 5' and 3' end-specific, as well as plus-, or minus-strand-specific oligonucleotides revealed that they represent VP1 linked to 5' terminal sequences of genome segment A- and B-specific plus strands. Pulse-chase experiments in combination with two-dimensional polyacrylamide gel electrophoresis revealed that labeled VP1 could be chased to replicative intermediate, to ssRNA, to dsRNA, and eventually to virion VPg-dsRNA and that VP1 could be released from all these structures by RNase treatment. We suggest that these results are most compatible with the model where a VP1-pN structure acts as a primer for viral RNA synthesis in vivo, a mechanism that has been shown to occur in vitro.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9614875     DOI: 10.1006/viro.1998.9137

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  9 in total

1.  The structure of a birnavirus polymerase reveals a distinct active site topology.

Authors:  Junhua Pan; Vikram N Vakharia; Yizhi Jane Tao
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-24       Impact factor: 11.205

Review 2.  Viruses of lower vertebrates.

Authors:  S Essbauer; W Ahne
Journal:  J Vet Med B Infect Dis Vet Public Health       Date:  2001-08

3.  Infectious bursal disease virus capsid protein VP3 interacts both with VP1, the RNA-dependent RNA polymerase, and with viral double-stranded RNA.

Authors:  Mirriam G J Tacken; Ben P H Peeters; Adri A M Thomas; Peter J M Rottier; Hein J Boot
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

4.  VP1, the putative RNA-dependent RNA polymerase of infectious bursal disease virus, forms complexes with the capsid protein VP3, leading to efficient encapsidation into virus-like particles.

Authors:  E Lombardo; A Maraver; J R Castón; J Rivera; A Fernández-Arias; A Serrano; J L Carrascosa; J F Rodriguez
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

5.  Identification and molecular characterization of the RNA polymerase-binding motif of infectious bursal disease virus inner capsid protein VP3.

Authors:  Antonio Maraver; Roberto Clemente; Jose Francisco Rodríguez; Eleuterio Lombardo
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

6.  Self-guanylylation of birnavirus VP1 does not require an intact polymerase activity site.

Authors:  Junhua Pan; Li Lin; Yizhi Jane Tao
Journal:  Virology       Date:  2009-10-04       Impact factor: 3.616

7.  The Structure of the RNA-Dependent RNA Polymerase of a Permutotetravirus Suggests a Link between Primer-Dependent and Primer-Independent Polymerases.

Authors:  Diego S Ferrero; Mònica Buxaderas; José F Rodríguez; Núria Verdaguer
Journal:  PLoS Pathog       Date:  2015-12-01       Impact factor: 6.823

Review 8.  The Infectious Pancreatic Necrosis Virus (IPNV) and its Virulence Determinants: What is Known and What Should be Known.

Authors:  Carlos P Dopazo
Journal:  Pathogens       Date:  2020-02-04

9.  Discovery of nonnucleoside inhibitors of polymerase from infectious pancreatic necrosis virus (IPNV).

Authors:  Melissa Bello-Pérez; Alberto Falcó; Vicente Galiano; Julio Coll; Luis Perez; José Antonio Encinar
Journal:  Drug Des Devel Ther       Date:  2018-07-30       Impact factor: 4.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.